Fig. 1From: Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort studyPatient inclusion and exclusion chart. From 234 eligible patients 53 had to be excluded as indicated on the right. 106 patients with UC and 75 patients with CD were included into the analysesBack to article page